Remicade and Pregnancy: Safety & Considerations for Expectant Mothers

Remicade (Infliximab)

- Pregnancy Category: B (According to the FDA)

Risk Summary:

- There are no adequate and well-controlled studies of infliximab in pregnant women. Animal studies have shown no evidence of harm to the fetus.

- The decision to use infliximab during pregnancy should be made in consultation with the patient's physician.

Clinical Considerations:

- Use only if clearly needed.

- Consider discontinuing infliximab in pregnancy if there is no improvement in symptoms.

Animal Studies:

- Teratogenicity: No evidence of harm to the fetus was observed in animal studies.

_This information is not intended as a substitute for the expertise and advice of a healthcare provider. Always consult with your healthcare provider before taking any medication during pregnancy or while breastfeeding._